Misuse and Diversion of Stimulants Prescribed for ADHD: A Systematic Review of the Literature
The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
Objective Recent studies have provided variable information on the frequency and context of diversion and the use of nonprescribed and prescribed stimulant medications in adolescent and young adult populations. The purpose of this systematic review of the literature is to evaluate the extent and characteristics of stimulant misuse and diversion in attention-deficit/hyperactivity disorder (ADHD) and non-ADHD individuals. Method We conducted a systematic review of the literature of available studies looking at misuse and diversion of prescription ADHD medications using misuse, diversion, stimulants, illicit use, and ADHD medications as key words for the search. Results We identified 21 studies representing 113,104 subjects. The studies reported rates of past year nonprescribed stimulant use to range from 5% to 9% in grade school- and high school-age children and 5% to 35% in college-age individuals. Lifetime rates of diversion ranged from 16% to 29% of students with stimulant prescriptions asked to give, sell, or trade their medications. Recent work suggests that whites, members of fraternities and sororities, individuals with lower grade point averages, use of immediate-release compared to extended-release preparations, and individuals who report ADHD symptoms are at highest risk for misusing and diverting stimulants. Reported reasons for use, misuse, and diversion of stimulants include to concentrate, improve alertness, "get high," or to experiment. Conclusions The literature…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“and there have been reports of abuse and misuse of stimulant ADHD medication (Kollins, MacDonald, & Rush, 2001; Wilens et al., 2008).”
From Stimulant ADHD medication and risk for substance abuse (2014) · cites this paper as Wilens et al., 2008
In the citing paper
“substantial data indicate that a minority of patients with ADHD divert their stimulant medication for misuse byothers 176 .”
From Attention-deficit/hyperactivity disorder (2015) · cites this paper as [176]
In the citing paper
“Given the burden of attention, behavioural and cognitive deficits often noted in children with ADHD and concerns about over prescription of medications with side effects [116], exercise could hold promise as an adjunctive treatment and requires testing in robust well-powered RCTs.”
From Exercise as Medicine for Mental and Substance Use Disorders: A Meta-review of the Benefits for Neuropsychiatric and Cognitive Outcomes (2020) · cites this paper as [116]
In the citing paper
“Long-acting preparations improve compliance and may decrease the potential for abuse, misuse, or recreational use.”
From Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder (2017) · cites this paper as [8]
In the citing paper
“the long-acting formulations are associated with a lower abuse potential compared with the shorter acting formulations”
From Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder (2017) · cites this paper as [8]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
The worldwide prevalence of ADHD: a systematic review and metaregression analysis
Polanczyk, G., de Lima, M. S., Horta, B. L., Biederman, J., & Rohde, L. A. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.6.942 · Cited by 5,346
Kessler, R. C., Adler, L., Barkley, R., Biederman, J., Conners, C. K., Demler, O., Faraone, S. V., Greenhill, L. L., Howes, M. J., Secnik, K., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.4.716 · Cited by 3,886
Self-citation(1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.12.1073 · Cited by 3,372
Pliszka, S. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e318054e724 · Cited by 1,765
The Worldwide prevalence of ADHD: is it an American condition?
Faraone, S. V., Sergeant, J. A., Gillberg, C., & Biederman, J. (2003) · Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam) · Cited by 1,516
Mannuzza, S. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820190067007 · Cited by 1,368
General hospital psychiatry: the Italian experience.
Faraone, S. V., Sergeant, J. A., Gillberg, C., & Biederman, J. (2003) · Europe PMC (PubMed Central) · Cited by 1,317
Diagnosis and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents
Goldman, L. S. (1998) · JAMA · doi:10.1001/jama.279.14.1100 · Cited by 1,082
Greenhill, L. L., Pliszka, S., & Dulcan, M. K. (2002) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200202001-00003 · Cited by 927
Volkow, N. D., Wang, G.-J., Fowler, J. S., Gatley, S. J., Logan, J., Ding, Y.-S., Hitzemann, R., & Pappas, N. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.10.1325 · Cited by 885
Cited by
Items 401–500 of 823
Blevins, D., Choi, C. J., Pavlicová, M., Martinez, D., Mariani, J. J., Grabowski, J. G., & LEVIN, F. R. (2020) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.108082 · Cited by 11
“A systematic review of more than 100,000 students showed that lifetime rates of prescription stimulant diversion occurred among a significant minority (16% to 29%) (Wilens et al., 2008).”
BackgroundHenry, T. R., Fogleman, N. D., Nugiel, T., & Cohen, J. R. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-02283-4 · Cited by 11
“Prior evidence suggests that ~70% of children with ADHD respond favorably to MPH [5, 38, 39], with response to MPH typically defined as a reduction in ADHD symptoms over a multi-month period of treatment [40].”
BackgroundFocus on Lisdexamfetamine: A Review of its use in Child and Adolescent Psychiatry.
(2010) · Europe PMC (PubMed Central) · Cited by 10
Response to Whitely: A caution from the coalface
Lévy, F. (2012) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867412444108 · Cited by 10
Saloner, B. K., Bachhuber, M. A., & Barry, C. L. (2016) · Psychiatric Services · doi:10.1176/appi.ps.201500245 · Cited by 10
Rubin-Kahana, D. S., Rubin-Kahana, Z., Kuperberg, M., Stryjer, R., & Yodashkin-Porat, D. (2020) · Journal of Addictive Diseases · doi:10.1080/10550887.2020.1747337 · Cited by 11
Cunill, R., Cervelló, X. C., González-Pinto, A. M., Arrojo, M., Bernardo, M., Sáiz, P. A., Flórez, G., Torrens, M., Tirado-Muñoz, J., Fonseca, F., et al. (2021) · Adicciones · doi:10.20882/adicciones.1569 · Cited by 13
“…Perez & Trujols, 2014), caution of treating physicians because of concerns about euphoric effects of psychostimulants, potential risk of abuse (Wilens et al., 2008a) or safety of stimulants especially methylphenidate which may enhance cardiovascular side effects of cocaine (Collins, Levin,…”
Use of stimulant substances among university students in tehran: a qualitative study.
Rahimi‐Movaghar, A., Khastoo, G., Moinolghorabaei, M., Yunesian, M., & Sadeghi, A. (2011) · PubMed Central · Cited by 12
Adler, L. A., Wilens, T. E., Zhang, S., Dittmann, R., D’Souza, D. N., Schuh, L. M., & Durell, T. M. (2012) · Clinical Therapeutics · doi:10.1016/j.clinthera.2011.12.015 · Cited by 13
Self-citationHarris, S., Nikulina, V., Gelpí-Acosta, C., Morton, C. M., Newsome, V., Gunn, A., Hoefinger, H., Aikins, R. D., Smith, V., Barry, V., et al. (2015) · AIMS Public Health · doi:10.3934/publichealth.2015.4.762 · Cited by 10
“help better understand such motivations [54] and lead to targeted interventions that could help”
BackgroundMasi, L., & Gignac, M. (2016) · Annales Médico-psychologiques revue psychiatrique · doi:10.1016/j.amp.2015.11.013 · Cited by 25
Simoni, Z. R. (2017) · Sociological Perspectives · doi:10.1177/0731121417691050 · Cited by 13
“Within the last 30 years in the United States, the number of children diagnosed and medicated for ADHD has increased (Olfson et al. 2003; Wilens et al. 2008).”
BackgroundSpencer, T. J., Bhide, P. G., Zhu, J., Faraone, S. V., Fitzgerald, M., Yule, A. M., Uchida, M., Spencer, A. E., Hall, A. M., Koster, A. J., et al. (2018) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.17m11609 · Cited by 10
Colaneri, N., Keim, S. A., & ADESMAN, A. R. (2018) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2017.0066 · Cited by 11
“…accompany many studies documenting an even greater prevalence of stimulant misuse and di-version in the college-aged population (Hall et al. 2005; Teter et al. 2006; White et al. 2006; DeSantis et al. 2008; Wilens et al. 2008; Rabiner et al. 2009; Garnier-Dykstra et al. 2012; Rabiner 2013).”
InfluentialPsychostimulants may block long-term memory formation via degraded sleep in healthy adults
Whitehurst, L. N., & Mednick, S. C. (2020) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2020.107342 · Cited by 11
Psychostimulant-Induced Gene Regulation in Corticostriatal Circuits
Steiner, H. (2010) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-12-374767-9.00029-9 · Cited by 14
Whelan, E., & Asbridge, M. (2013) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2013.01.007 · Cited by 12
“, 2011), and to stimulants diversion (Rabiner et al., 2009; Wilens et al., 2008).”
Psychostimulant-Induced Gene Regulation in Striatal Circuits
Steiner, H. (2016) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-12-802206-1.00031-3 · Cited by 10
Lee, S., Choi, J.-W., Kim, K.-M., Kim, J. W., Kim, S.-Y., Kang, T.-W., Kim, J. I., Lee, Y. S., Kim, B., Han, D. H., et al. (2016) · Journal of korean Academy of Child and Adolescent Psychiatry · doi:10.5765/jkacap.2016.27.4.236 · Cited by 10
Li, Y., Liu, W., Zhu, Y., Liu, X., & Winterstein, A. G. (2017) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000759 · Cited by 10
Counterfeit formulations: analytical perspective on anorectics
Bonsu, D. O. M., Afoakwah, C., & Aguilar-Caballos, M. (2021) · Forensic Toxicology · doi:10.1007/s11419-020-00564-5 · Cited by 7
Callovini, T., Janiri, D., Segatori, D., Mastroeni, G., Kotzalidis, G. D., Nicola, M. D., & Sani, G. (2024) · Pharmaceuticals · doi:10.3390/ph17081076 · Cited by 11
“This is particularly significant considering the absence of clear treatment guidelines, as clinicians may hesitate to escalate doses to optimal levels for individuals with ADHD and SUD [36,37].”
BackgroundEarly-life risperidone enhances locomotor responses to amphetamine during adulthood
Stubbeman, B. L., Brown, C. J., Yates, J. R., & Bardgett, M. E. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.07.025 · Cited by 9
The impact of psychostimulants on sustained attention over a 24-h period
Whitehurst, L. N., Agosta, S., Castaños, R., Battelli, L., & Mednick, S. C. (2019) · Cognition · doi:10.1016/j.cognition.2019.104015 · Cited by 11
“However, considering the growing trend in the use of prescription stimulant medications by healthy young adults (Swanson et al., 2011; Wilens et al., 2008), understanding subsequent health and cognitive consequences associated with non-medically necessary stimulant use is becoming more essential.”
BackgroundMagnetic Resonance Spectroscopy Studies of Attention Deficit Hyperactivity Disorder
O’Neill, J., Levitt, J. G., & Alger, J. R. (2012) · Springer eBooks · doi:10.1007/978-1-4419-5864-8_18 · Cited by 10
Chen, C., Yeh, H.-H. H., Fang, S., Wu, E. C., Chang, I., & Lin, K. (2012) · Psychiatric Services · doi:10.1176/appi.ps.201100473 · Cited by 9
Issy, A. C., & Bel, E. A. D. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.12.042 · Cited by 10
Review of State Medication Policies/Guidelines Regarding Psychotropic Medications in Public Schools
Ryan, J. B., Katsiyannis, A., Losinski, M. L., Reid, R. R., & Ellis, C. R. (2013) · Journal of Child and Family Studies · doi:10.1007/s10826-013-9805-3 · Cited by 11
“Diversion of medication is a serious concern to schools, and unsupervised possession or access of a controlled substance can exacerbate the problem (Wilens et al. 2008).”
BackgroundFrölich, J., Banaschewski, T., Spanagel, R., Döpfner, M., & Lehmkuhl, G. (2012) · Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie · doi:10.1024/1422-4917/a000185 · Cited by 10
Alcantara, J., & Davis, J. (2010) · EXPLORE · doi:10.1016/j.explore.2010.02.001 · Cited by 10
Heyes, A., & Boardley, I. D. (2019) · Drugs Education Prevention and Policy · doi:10.1080/09687637.2019.1586831 · Cited by 12
“…to determine categorically, lifetime use of such drugs for CE purposes is estimated to be between 5 and 35% in North American (Smith & Farah, 2011; Wilens et al., 2008) and between 1 and 10% in the UK and Europe (Franke et al., 2011; Ott & Biller-Andorno, 2014; Singh, Bard, & Jackson, 2014).”
BackgroundSummit, A. G., Moseley, M. C., Chaku, N., Elam, K. K., Jacobs, W., Lederer, A. M., Vaughan, E. L., & Quinn, P. D. (2024) · Addiction · doi:10.1111/add.16716 · Cited by 12
Augmentation de l’abus de méthylphénidate : repérage et profils sur 13 années
Guerra, C., Soeiro, T., Lacroix, C., Jouve, É., Micallef, J., & Frauger, É. (2022) · Therapies · doi:10.1016/j.therap.2022.03.006 · Cited by 9
Lamoureux, L., Beverley, J. A., Steiner, H., & Marinelli, M. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-023-01777-z · Cited by 7
“Therefore, accidental co-exposure to these drugs can occur in patients on SSRIs who then use MP recreationally or as a cognitive enhancer [28 – 30].”
Wu, L.-T. T., Swartz, M. S., Brady, K. T., Blazer, D. G., & Hoyle, R. H. (2014) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2014.09.004 · Cited by 9
“Depending on the survey samples, an estimated 5e35% of college-aged young adults reported past-year nonmedical stimulant use (NMSU) (Wilens et al., 2008).”
BackgroundRudski, J. M. (2014) · AJOB Empirical Bioethics · doi:10.1080/23294515.2013.850122 · Cited by 8
“…predominant group of participants, are a particularly pertinent population, being among the most likely to use enhancers (Forlini and Racine 2011; McCabe et al. 2005; Wilens et al. 2008), but their attitudes toward enhancement may differ from those of other stakeholders (Racine and Forlini 2009).”
BackgroundNon-medical Use of Medications in Middle and Low Income Countries
Afshari, R. (2014) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 8
Bray, B., Scholl, J. L., Tu, W., Watt, M. J., Renner, K. J., & Forster, G. L. (2016) · Brain Research · doi:10.1016/j.brainres.2016.05.030 · Cited by 11
“Amphetamine dependence is a global health problem with a high incidence of relapse and few successful treatment options (Fone and Nutt, 2005; Heal et al., 2013; Pomerleau et al., 2012; Wilens et al., 2008).”
BackgroundA questionnaire study investigating future pharmacists’ use of, and views on cognitive enhancers
Hanna, L., Rainey, J., & Hall, M. (2018) · Research Portal (Queen's University Belfast) · Cited by 9
Acceptability of Neuroscientific Interventions in Education
Schmied, A., Varma, S., & Dubinsky, J. M. (2021) · Science and Engineering Ethics · doi:10.1007/s11948-021-00328-3 · Cited by 12
Prevalence of methylphenidate use by Master of Medicine students at a South African university
Louw, W. A. N., & Davids, R. A. (2021) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2021-140991 · Cited by 13
Baladi, M. G., Nielsen, S. M., Umpierre, A. D., Hanson, G. R., & Fleckenstein, A. E. (2014) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000094 · Cited by 8
“…such as MPD, are clinically effective in treating the symptoms of ADHD, their relatively widespread availability has raised public health concerns (Wilens et al., 2008; Kaye and Darke, 2012) with regard to their abuse potential and nonmedical use among adults in general, as well as among college…”
BackgroundAnderson, D., Watt, S., & Shanley, D. C. (2013) · Social Psychology of Education · doi:10.1007/s11218-013-9235-5 · Cited by 9
Humility Pills: Building an Ethics of Cognitive Enhancement
Goodman, R. (2014) · The Journal of Medicine and Philosophy A Forum for Bioethics and Philosophy of Medicine · doi:10.1093/jmp/jhu017 · Cited by 11
Methylphenidate toxicosis in dogs: 128 cases (2001–2008)
Genovese, D. W., Gwaltney‐Brant, S. M., & Slater, M. R. (2010) · Journal of the American Veterinary Medical Association · doi:10.2460/javma.237.12.1438 · Cited by 8
“048 [8]).”
OROS methylphenidate for the treatment of adults with attention-deficit/hyperactivity disorder
Ramos‐Quiroga, J. A., Corominas, M., Cervelló, X. C., Bosch, R., & Casas, M. (2009) · Expert Review of Neurotherapeutics · doi:10.1586/ern.09.65 · Cited by 7
Social contextual risk factors for stimulant use among adolescent American Indians
Spillane, N. S., Weyandt, L. L., Oster, D. R., & Padovano, H. T. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.06.032 · Cited by 10
“However, research has also demonstrated that individuals with ADHD symptoms are more likely to take part in greater stimulant misuse (Wilens et al., 2008).”
BackgroundBjønness, J. (2019) · Drugs Education Prevention and Policy · doi:10.1080/09687637.2019.1590530 · Cited by 10
Substance Use and Dual Diagnosis Disorders: Future Epidemiology, Determinants, and Policies
Saddichha, S., Schütz, C. G., Sinha, B. N. P., & Manjunatha, N. (2015) · BioMed Research International · doi:10.1155/2015/145905 · Cited by 11
“Frequent khat use in the long-term has been associated with various health effects, including oesophagitis, gastritis, duodenal ulcer, hepatic cirrhosis, autoimmune hepatitis, migraine, cerebral haemorrhage, pulmonary oedema, and myocardial infarction [5, 6].”
Constantinou, D., & Aguiyi, I. (2022) · Frontiers in Sports and Active Living · doi:10.3389/fspor.2022.744650 · Cited by 14
Elia, J., Wilson, Z., Porta, L. S. L., Algon, S., Prowler, M. L., Cartwright, S., McKenna, P. A., Laracy, S. D., Takeda, T., & Borgmann‐Winter, K. E. (2011) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.11.11 · Cited by 9
Drug Class Review: Pharmacologic Treatments for Attention Deficit Hyperactivity Disorder
McDonagh, M. S., & Peterson, K. (2011) · Cited by 7
Cognitive Enhancement in Humans
Dresler, M., & Repantis, D. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-417042-1.00011-5 · Cited by 7
Strange Routes of Administration for Substances of Abuse
Allen, J. R., & Bridge, W. J. (2017) · American Journal of Psychiatry Residents Journal · doi:10.1176/appi.ajp-rj.2017.121203 · Cited by 7
Bastiaens, L., Scott, O., & Galus, J. (2018) · Psychiatric Quarterly · doi:10.1007/s11126-018-9602-7 · Cited by 9
Moss, C. M., Metzger, K. B., Carey, M. E., Blum, N. J., Curry, A. E., & Power, T. J. (2020) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0000000000000772 · Cited by 8
A prevalência da depressão pós-parto e suas consequências em mulheres no Brasil
de Souza, N. K. P., de Magalhães, E. Q., & Rodrigues, O. M. (2021) · Research Society and Development · doi:10.33448/rsd-v10i15.23272 · Cited by 23
Diversion and misuse of pharmaceutical stimulants among illicit drug users
Kaye, S. S., Darke, S. G., & Torok, M. H. (2013) · Addiction Research & Theory · doi:10.3109/16066359.2013.779677 · Cited by 10
“…stimulants has focused primarily on adolescents and college students, with increasing evidence to suggest that these medications are being used to improve attention, concentration and alertness related to academic performance (Greely et al., 2008; Lakhan & Kirchgessner, 2012; Wilens et al., 2008).”
BackgroundPeut-on prescrire des psychostimulants chez un étudiant sain ? Exemple d’un cas clinique
Micoulaud‐Franchi, J., Vion‐Dury, J., & Lançon, C. (2012) · Therapies · doi:10.2515/therapie/2012026 · Cited by 7
“[13,14] Troisièmement, la demande de psychostimulant peut être un symptôme d’abus ou de dépendance.”
Attention-Deficit/Hyperactivity Disorders
Walitza, S., Romanos, M., Greenhill, L. L., & Banaschewski, T. (2014) · Springer eBooks · doi:10.1007/978-3-7091-1501-5_12 · Cited by 8
Mantyh, W. G., Auger, R. R., Morgenthaler, T. I., Silber, M. H., & Moore, W. R. (2016) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.5788 · Cited by 7
“12,15,16 In one study, up to 8% of college students with ADHD reported intranasal use of their prescribed stimulant medication over the past 6 months, and 31% reported taking larger or more frequent doses than prescribed.”
CONSUMO DE ESTIMULANTES CEREBRAIS EM ACADÊMICOS DA ÁREA DA SAÚDE NA CIDADE DE PONTA GROSSA-PR
CORDEIRO, N., & Pinto, R. M. C. (2017) · Visão Acadêmica · doi:10.5380/acd.v18i2.53234 · Cited by 51
Nano-biosensors and Nano-aptasensors for Stimulant Detection
Ebrahimi, S., & Nahli, R. E. (2018) · Environmental chemistry for a sustainable world · doi:10.1007/978-3-319-98708-8_6 · Cited by 7
Family structure and the gender gap in ADHD
Bedard, K., & Witman, A. E. (2019) · Review of Economics of the Household · doi:10.1007/s11150-019-09476-9 · Cited by 7
Perspectives of US Adolescents on Diverted Stimulant Use
Hadler, N. L., Strome, A. L., Waselewski, M. E., Herbert, K., Harper, C., & Chang, T. (2021) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2021.04.010 · Cited by 7
Glannon, W. (2017) · Springer eBooks · doi:10.1007/978-3-319-54651-3_3 · Cited by 8
Baweja, R. K., Waschbusch, D. A., Kong, L., Jairath, B., Baweja, R., Hameed, U., & Waxmonsky, J. G. (2025) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2025.114471 · Cited by 9
Community Psychology: Getting to Work
McMillan, D. W. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108678971.004 · Cited by 7
Adolescent Patient Education Regarding ADHD Stimulant Diversion And Misuse
Colaneri, N., Keim, S. A., & ADESMAN, A. R. (2016) · Patient Education and Counseling · doi:10.1016/j.pec.2016.08.023 · Cited by 6
Reviewing the role of emerging therapies in the ADHD armamentarium
Childress, A. C., Beltran, N., Supnet, C., & Weiss, M. D. (2020) · Expert Opinion on Emerging Drugs · doi:10.1080/14728214.2020.1846718 · Cited by 9
Dutta, C. N., Christov‐Moore, L., Ombao, H., & Douglas, P. K. (2022) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2022.938501 · Cited by 10
Specificity in genetic and environmental risk for prescription opioid misuse and heroin use
Dash, G. F., Gizer, I. R., Martin, N. G., & Slutske, W. S. (2023) · Psychological Medicine · doi:10.1017/s003329172300034x · Cited by 8
“…stimulants are also used more frequently in a manner consistent with illicit drug use (e.g. intranasal administration) (Butler et al., 2021; Wilens et al., 2008), which may indicate that prescription stimulant misuse aligns more closely with use of other illicit drugs than with other…”
Ramsay, J. R., & Rostain, A. L. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781139035491.030 · Cited by 8
Cowles, B. J. (2009) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s6733 · Cited by 11
“One review of misuse and diversion described the rate of high school and college students who sold, traded, or gave away their stimulant medications as high as 16% to 29%.(16) Setlik et al described a 76% increase in poison control center calls related to adolescents abusing stimulant medications over the period of 19…”
ADHD, Conduct Disorder, Substance Use Disorder, and Nonprescription Stimulant Use
Brook, J. S., Balka, E. B., Zhang, C., & Brook, D. W. (2014) · Journal of Attention Disorders · doi:10.1177/1087054714528535 · Cited by 7
“Only two investigator teams have assessed the role of conduct problems or CD in the relationship of ADHD to the NMU of stimulants (Van Eck et al., 2012; Wilens et al., 2008; Wilens et al., 2006).”
BackgroundResultInfluentialStudy Drugs “Don’t Make You Smarter”
Kolar, K. (2015) · Contemporary Drug Problems · doi:10.1177/0091450915614050 · Cited by 7
“2 An opportunity for conceptualizing drug acceptability along more nuanced lines of assessment is suggested by the academic achievement–oriented illicit substance use of students to facilitate alertness and studying (DeSantis & Hane, 2010; Vrecko, 2013; White et al., 2006; Wilens et al. 2008).”
Backgroundde Oliveira, L. B., Parreiras, J. A. R., Sebastião, E. C. D. O., & da Silva, G. N. (2019) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.65.6.870 · Cited by 8
ADHD in College Students - a Guide for Clinicians and Administrators
Winkler, A., Bohle-Frankel, B., White, L. A., Strauss, G. D., & Gottlieb, D. T. (2020) · Current Psychopharmacologye · doi:10.2174/2211556009999200616132427 · Cited by 6
Medical Students’ Attitudes Towards Pharmacological Cognitive Enhancement With Methylphenidate
Erasmus, N., & Kotzé, C. (2020) · Academic Psychiatry · doi:10.1007/s40596-020-01303-z · Cited by 7
Levy, N. L. (2012) · Wiley Interdisciplinary Reviews Cognitive Science · doi:10.1002/wcs.1157 · Cited by 13
King, N., & Dafny, N. (2023) · Journal of Experimental Neurology · doi:10.33696/neurol.4.070 · Cited by 7
A Demanding Reality: Print-Media Advertising and Selling Smartness in a Knowledge Economy
Hatt, B., & Otto, S. (2011) · Educational Studies · doi:10.1080/00131946.2011.621075 · Cited by 6
“To date, researchers’ attention and inquiry remains on the diversion or outright stealing of short-acting (rather than time-released) ADHD stimulant medications by children, adolescents, and college-aged youth, usually to gain a competitive advantage in school or college (Wilens et al. 2008).”
BackgroundMcLarnon, M. E., Darredeau, C., Chan, J., & Barrett, S. P. (2013) · Journal of Substance Use · doi:10.3109/14659891.2013.845697 · Cited by 11
“prescription drug misuse literature (Wilens et al., 2008).”
BackgroundInfluentialNowak, K., Chłopaś‐Konowałek, A., Szpot, P., & Zawadzki, M. (2025) · Journal of Xenobiotics · doi:10.3390/jox15010015 · Cited by 7
Dave, A. A., & Cabrera, L. Y. (2020) · Journal of Cognitive Enhancement · doi:10.1007/s41465-020-00163-7 · Cited by 5
Mache, S., Bernburg, M., Groneberg, D. A., & Harth, V. (2020) · Work · doi:10.3233/wor-203279 · Cited by 7
“A meta-analysis examining prevalence rate of stimulant usage found a past-year prevalence rate of 5–9% in high schools and universities [31].”
Ricci, G., Busardò, F. P., Gibelli, F., Sirignano, A., & Brunetti, P. (2021) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2021.2029404 · Cited by 8
Neuroenhancement: State of the Art and Future Perspectives.
Marazziti, D., Avella, M. T., Ivaldi, T., Palermo, S., Massa, L., Vecchia, A. D., Basile, L., & Mucci, F. (2021) · PubMed Central · doi:10.36131/cnfioritieditore20210303 · Cited by 16
“…cognitive performances, especially amongst students, as they are convinced that a relaxed brain is more efficient (Mache et al., 2012; Maier et al., 2013). once a week (Outram, 2010), with a constant and progressive increase from high schools to college (McCabe et al., 2005; Wilens et al., 2008).”
BackgroundPeña, I. D., Ahn, H. S., Ryu, J. H., Shin, C. Y., Park, I.-H., & Cheong, J. H. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.05.057 · Cited by 7
Dobie, C., Wb, D., Heim, C. C., Huxsahl, J. E., Karasov, R., Neumann, A. V., & Spinner, P. (2012) · Cited by 10
Treatment of Comorbid Substance Use Disorders and ADHD in Youth
Carrellas, N. W., Wilens, T. E., & Anselmo, R. (2016) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-016-0072-y · Cited by 7
Self-citationvan Haaren, F. (2016) · Behavior Analysis Research and Practice · doi:10.1037/bar0000049 · Cited by 6
Milhet, M., & Langlois, E. (2017) · Déviance et Société · doi:10.3917/ds.414.0511 · Cited by 5
Illicit use of Methylphenidate: the other side of the medical prescription
Pereira, S. P. M., Ferreira, A., Azevedo, A., Barroso, C., & Monteiro, V. (2018) · Nascer e crescer · doi:10.25753/birthgrowthmj.v27.i2.13022 · Cited by 14
Medikamentöse Therapie der Aufmerksamkeitsdefizit‑/Hyperaktivitätsstörung im Erwachsenenalter
Retz, W., Retz‐Junginger, P., Davydenko, S., & Rösler, M. (2020) · Der Nervenarzt · doi:10.1007/s00115-020-00891-3 · Cited by 5
Khodaverdi, Z., Moreau, D., & Garber, C. E. (2021) · Child Neuropsychology · doi:10.1080/09297049.2021.1992378 · Cited by 6
“However, due to the long-term side effects (Buitelaar & Medori, 2010; Dela Peña et al., 2013; Wilens et al., 2008) and a relatively high non-response rate (20–25%) (Childress & Sallee, 2014; Shyu et al.”
BackgroundArnavut, E., Hamilton, J., Yao, R., Sajjad, M., Hadjiargyrou, M., Komatsu, D. E., & Thanos, P. K. (2022) · Synapse · doi:10.1002/syn.22243 · Cited by 8
“These individuals may use MP periodically rather than daily to enhance performance throughout the school week with weekends off or solely during the academic year with long school breaks off (Fallah et al., 2018; Lakhan &Kirchgessner, 2012;Mache et al., 2012;Wilens et al., 2008).”
BackgroundFroehlich, T. E. (2017) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0000000000000513 · Cited by 5
Navarro, S. R., & Rojas, P. (2019) · Athenea Digital Revista de pensamiento e investigación social · doi:10.5565/rev/athenea.2465 · Cited by 5
Sattler, S., & Linden, P. (2021) · Social Science Research · doi:10.1016/j.ssresearch.2021.102559 · Cited by 7
Metadata
- Authors
- WILENS, T. E., ADLER, L. A., ADAMS, J., SGAMBATI, S., ROTROSEN, J., SAWTELLE, R., UTZINGER, L., & FUSILLO, S.
- Affiliations
- Harvard University (US)
- Corresponding author
- WILENS, TIMOTHY E.
- Venue
- Journal of the American Academy of Child & Adolescent Psychiatry
- Publisher
- Elsevier BV
- Published
- 2008-01
- Volume
- 47
- Issue
- 1
- Pages
- 21-31
- ISSN
- 0890-8567 (ISSN-L)
- OpenAlex
- W1970031540
- Cited by
- 824
- References
- 56
- Citations by year
- 2026: 16 · 2025: 44 · 2024: 21 · 2023: 17 · 2022: 26 · 2021: 87 · 2020: 43 · 2019: 50 · 2018: 36 · 2017: 49 · 2016: 60 · 2015: 52 · 2014: 73 · 2013: 49 · 2012: 70
- FWCI
- 5.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Journal of the American Academy of Child & Adolescent Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- the National Institute of Drug Abuse (U10 DA15831 and U10 DA13046)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Social Sciences › Arts and Humanities › Philosophy › Neuroethics, Human Enhancement, Biomedical Innovations
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Keywords
- stimulant abuse, prescription drug diversion, ADHD medication, adolescents, young adults, university students, risk factors
- MeSH terms
- Adolescent, Adult, Amphetamines, Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, Child, Cross-Sectional Studies, Female, Health Surveys, Humans, Male, Methylphenidate, Drug Prescriptions, Self Administration, Illicit Drugs, United States, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.